Related Experiment Video

Updated: Aug 9, 2026

A Multiplexed Luciferase-based Screening Platform for Interrogating Cancer-associated Signal Transduction in Cultured Cells
10:13

A Multiplexed Luciferase-based Screening Platform for Interrogating Cancer-associated Signal Transduction in Cultured Cells

Published on: July 3, 2013

Insights into cancer therapeutic design based on p53 and TRAIL receptor signaling

W S El-Deiry1

  • 1Laboratory of Molecular Oncology and Cell Cycle Regulation, Department of Medicine, Howard Hughes Medical Institute, University of Pennsylvania School of Medicine, Philadelphia, PA 19104, USA. wafik@mail.med.upenn.edu

Cell Death and Differentiation
|November 1, 2001
PubMed

Insights

Understanding p53 and TRAIL pathways in cancer cell death offers new therapeutic strategies. Exploiting tissue-specific responses can improve combination cancer therapies by targeting apoptotic effectors.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cell Death Research

Background:

  • The p53 tumor suppressor and TRAIL (tumor necrosis factor-related apoptosis-inducing ligand) pathways are crucial in cancer cell death.
  • p53 regulates cell cycle arrest and apoptosis, with signals transduced to various apoptotic effectors.
  • TRAIL signaling, while promising, shares similarities with toxic Fas and TNF pathways.

Purpose of the Study:

  • To explore emerging cell death pathways downstream of p53 and TRAIL.
  • To identify strategies for improving cancer therapeutic design.
  • To investigate the exploitation of tissue-specific cell death responses.

Main Methods:

  • Analysis of signaling cascades downstream of p53 and TRAIL.
  • Investigation of caspase activation (cytoplasmic and mitochondrial).
  • Evaluation of tissue-specific cell death responses.

Main Results:

  • p53 signals to multiple apoptotic effectors, involving cytoplasmic and mitochondrial caspase activation.
  • TRAIL pathway shows therapeutic potential despite similarities to Fas and TNF.
  • Tissue specificity in cell death responses was identified as a key feature.

Conclusions:

  • Knowledge of p53 and TRAIL pathways informs improved cancer therapeutic design.
  • Tissue-specific responses can be leveraged to enhance combination cancer therapies.
  • Further research into p53-targeted therapies and effector modulation may improve treatment outcomes.

More Related Videos

Yeast As a Chassis for Developing Functional Assays to Study Human P5314:57

Yeast As a Chassis for Developing Functional Assays to Study Human P53

Published on: August 4, 2019

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts10:27

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Published on: July 25, 2020

Related Concept Videos

Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...